— Know what they know.
Not Investment Advice
Also trades as: ALVO (NASDAQ) · $vol 5M

ALVOW NASDAQ

Alvotech
1W: -61.4% 1M: -43.3% 3M: -15.7% YTD: -78.2% 1Y: -85.2% 3Y: -88.7%
$0.17
-0.03 (-14.96%)
 
Weekly Expected Move ±62.4%
$-0 $0 $0 $1 $1
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 30 · $1.6B mcap · 103M float · 0.0037% daily turnover · Short 59% of daily vol
Credit Risk of going bust: higher than 88% of companies Debt: 46.1% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.02 (down 90%), Alvotech would be worth roughly what it owes.
Total debt $1.45B against a stock market value of $1.69B.
Distance to default 1.86 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $685.8M (short-term plus half of long-term), stock volatility 81.2%; Altman Z'' -4.58. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$1.5B +21.8% ▲
5Y CAGR: +25.7%
Total Liabilities
$1.8B +8.4% ▲
5Y CAGR: +5.7%
Shareholders Equity
-$284M +31.1% ▲
Cash & Investments
$172M +235.1% ▲
5Y CAGR: +40.3%
Total Debt
$1.4B +21.8% ▲
5Y CAGR: +16.4%
Net Debt
$1.3B +12.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$18M$66M$11M$51M$172M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$18M$66M$11M$51M$172M
Net Receivables$54M$71M$87M$252M$70M
Inventory$39M$71M$74M$128M$220M
Other Current Assets$0$851K$0$0$112M
Total Current Assets$120M$231M$195M$455M$574M
Property, Plant & Equip.$205M$268M$357M$410M$356M
Goodwill & Intangibles$34M$37M$31M$32M$95M
Long-Term Investments$55M$49M$18M$23M$0
Other Non-Current Assets$13M$34M$39M$4M$270M
Total Non-Current Assets$478M$598M$755M$766M$913M
Total Assets$598M$828M$950M$1.2B$1.5B
— Liabilities —
Accounts Payable$29M$49M$81M$67M$126M
Short-Term Debt$3M$20M$38M$33M$37M
Deferred Revenue$30M$37M$59M$16M$0
Other Current Liabilities$0$0$34M$7M$128M
Total Current Liabilities$112M$167M$261M$193M$304M
Long-Term Debt$398M$745M$922M$1.0B$1.3B
Other Non-Current Liab.$64M$388M$521M$210M$59M
Total Non-Current Liabilities$622M$1.2B$1.6B$1.4B$1.5B
Total Liabilities$734M$1.4B$1.9B$1.6B$1.8B
— Equity —
Common Stock$135K$2M$2M$3M$3M
Retained Earnings-$1.1B-$1.7B-$2.2B-$2.4B-$2.4B
Accumulated OCI$5M$29M$41M$15M$17M
Total Stockholders Equity-$136M-$564M-$932M-$413M-$284M
Total Liabilities & Equity$598M$828M$950M$1.2B$1.5B
— Key Metrics —
Total Debt$523M$805M$1.1B$1.2B$1.4B
Net Debt$505M$739M$1.1B$1.1B$1.3B
Total Investments$55M$49M$18M$23M$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms